60 EXTENDED CC-486 (ORAL AZACITIDINE) DOSING IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), ACUTE MYELOID LEUKEMIA (AML), OR CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML): SAFETY, TOLERABILITY, AND RESPONSE

Saved in:
Bibliographic Details
Published in:Leukemia research Vol. 39; pp. S29 - S30
Main Authors: Savona, M.R, Kolibaba, K, Conkling, P, Kingsley, E.C, Becerra, C, Morris, J.C, Rifkin, R.M, Laille, E, Kellerman, A, Ukrainskyj, S.M, Dong, Q, Skikne, B.S
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-04-2015
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0145-2126
1873-5835
DOI:10.1016/S0145-2126(15)30061-8